NLRP12 and cancer: The formation of the NLRP12‐PANoptosome in response to heme plus PAMPs or TNF suggests a critical role for NLRP12‐mediated PANoptosis in innate immune responses to conditions where free heme is released, including haemolytic diseases, infections, inflammatory conditions and some cancers.